frankz2
Active member
The first round of testing started and there was a few promising logs now we have entered round two. From what I understand the second batch is a bit different than the first. And they have added something to the carrier of the oral version to aid the absorption.
This is correct. Both the oral and TD versions have received updates in an effort to further increase the bioavailability of the -epi.